Computational Biology Market Share

Request Free Sample Copy

Report ID: 3921
Published Date: May 08, 2025
Report Format: PDF, PPT

Buy Now

North American Market Forecast

In computational biology market, North American region is estimated to hold significant share by the end of 2037, due to the growing R&D activities, coupled with the high investment in research activities.

The growing foothold of the United States in synthetic biology is predicted to promote lucrative opportunities for the market expansion. The advancement of the region in the application of machine learning tools and analytical tools will further influence the market growth.

APAC Market Statistics

By 2037, Asia Pacific region in computational biology market is estimated to hold significant revenue share. The increasing presence of contract research organizations in the region that reduce the cost of drug development for many pharmaceutical industries will propel the market revenue.

The Asian market is popular for the manufacturing of generic drugs and biosimilars which is much essential to decrease healthcare expenditure and is set to drive the use of computational biology in the region.

Browse key industry insights with market data tables & charts from the report:

Computational Biology Market size to exceed $101.88 billion by 2037 | 20.1% CAGR Forecast

Frequently Asked Questions (FAQ)

Computational Biology Market in 2025 is assessed at USD 10.93 billion.

The global market size was valued at over USD 9.42 billion in 2024 and is expected to expand at a CAGR of around 20.1%, surpassing USD 101.88 billion revenue by 2037.

North America is poised to secure largest share by 2037, attributed to growing R&D activities and high investment in research activities.

The major players in the market include Dassault Systèmes SE, Certara Inc., Instem Group, Compugen, Chemical Computing Group ULC, Rhenovia Pharma SAS, Nimbus Discovery LLC, Insilico Biotechnology AG, Genedata AG.